Application of Tumor Treating Fields (TTFields) to tumor cells augments their membrane permeability

被引：0
|
作者：
Koltun, B. [1 ]
Voloshin, T. [1 ]
Kan, T. [1 ]
Koren, L. [1 ]
Porat, Y. [1 ]
Volodin, A. [1 ]
Kaynan, N. [1 ]
Klein-Goldberg, A. [1 ]
Paz, R. [1 ]
Brant, B. [1 ]
Barsheshet, Y. [1 ]
Zemer-Tov, E. [1 ]
Ehrle, S. [2 ]
Haber, A. [1 ]
Giladi, M. [1 ]
Weinberg, U. [1 ]
Palti, Y. [1 ]
机构：
[1] Novocure Ltd, Haifa, Israel
[2] Novocure GmbH, Munich, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2022年 / 198卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P07-1
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [21] THE BLOOD BRAIN BARRIER (BBB) PERMEABILITY IS ALTERED BY TUMOR TREATING FIELDS (TTFIELDS) IN VIVO
    Schulz, Ellina
    Kessler, Almuth F.
    Salvador, Ellaine
    Domrose, Dominik
    Burek, Malgorzata
    Brami, Catherine Tempel
    Sela, Tali Voloshin
    Giladi, Moshe
    Ernestus, Ralf-Ingo
    Lohr, Mario
    Forster, Carola
    Hagemann, Carsten
    NEURO-ONCOLOGY, 2019, 21 : 82 - 82
  • [22] Comprehensive approaches to increasing Tumor Treating Fields (TTFields) dose at the tumor
    Kinzel, A.
    Bomzon, Z.
    Urman, N.
    Naveh, A.
    Marciano, T.
    Berger, B.
    Ochovosky, S.
    Kuplennik, N.
    Wassermann, Y.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S225 - S225
  • [23] Transcriptomic Response to Tumor Treating Fields (TTFields) Across Tumor Types
    Katsir, K. Wainer
    Lavy-Shahaf, G.
    Fishman, H.
    Ene, H.
    Frechtel-Gerzi, R.
    Martinez-Conde, A.
    Dor-On, E.
    Davidi, S.
    Jacobovitch, S.
    Tzchori, I.
    Porat, Y.
    Ding, L.
    Story, M. D.
    Du, R.
    Kahlert, U.
    Mannarino, L.
    Mirimao, F.
    Lupi, M.
    D'Incalci, M.
    Haber, A.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S431 - S431
  • [24] EVALUATING THE SAFETY OF TUMOR TREATING FIELDS (TTFIELDS) APPLICATION TO THE TORSO - IN VIVO STUDIES
    Davidi, Shiri
    Blat, Roni
    Munster, Mijal
    Shteingauz, Anna
    Cahal, Shay
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    Giladi, Moshe
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A105 - A105
  • [25] Evaluation of the Safety of Tumor Treating Fields (TTFields) Application to the Torso - in Vivo Studies
    Davidi, S.
    Blatt, R.
    Munster, M.
    Shteingauz, A.
    Cahal, S.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S386 - S387
  • [26] Treatment of gastric cancer cells with tumor treating fields (TTFields) and concomitant FOLFOX
    Flint-Brodsly, Naama
    Zeevi, Einav
    Wainer-Katsir, Kerem
    Fishman, Hila
    Martinez-Conde, Antonia
    Dor-On, Eyal
    Munster, Mijal
    Porat, Yaara
    Voloshin, Tali
    Davidi, Shiri
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2023, 83 (07)
  • [27] Treatment of pancreatic cancer cells with tumor treating fields (TTFields) and PARP inhibitors
    Ene, Hila
    Ben Meir, Kerem
    Martinez-Conde, Antonia
    Frechtel-Gerzi, Roni
    Gabay, Hila
    Gerasimova, Daria
    Engelman, Rotem
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (06)
  • [28] The blood brain barrier (BBB) permeability is altered by Tumor Treating Fields (TTFields) in vitro and in vivo
    Kessler, A. F.
    Salvador, E.
    Schaeffer, C.
    Burek, M.
    Ruschig, U.
    Tempel-Brami, C.
    Sela, Voloshin T.
    Giladi, M.
    Ernestus, R. -, I
    Loehr, M.
    Foerster, C.
    Hagemann, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S60 - S60
  • [29] SENSITIVITY OF TUMOR TREATING FIELDS (TTFIELDS) TREATMENT PLANNING TO TUMOR SEGMENTATION ERRORS
    Ze'evi, Oshrit
    Marciano, Tal
    Naveh, Ariel
    NEURO-ONCOLOGY, 2022, 24 : 292 - 292
  • [30] INDUCTION OF ANTI-TUMOR IMMUNITY BY TUMOR TREATING FIELDS (TTFIELDS) IN GLIOBLASTOMA
    Chen, Dongjiang
    Le, Son
    Hutchinson, Tarun
    Jin, Dan
    Sebastian, Mathew
    Liu, Tianyi
    Ghinaseddin, Ashley
    Rahman, Maryam
    Tran, David
    NEURO-ONCOLOGY, 2021, 23 : 100 - 100
12345